NEOGEN CHEMICALS growth ratios

·ChemicalsChart ›
ProfitabilityGrowthCreditLiquidityWorking capitalDividend yieldDuPontCAGR
Per cent unless marked ×
Tap a line for its trendFY26Mar 2026FY25Mar 2025FY24Mar 2024FY22 and earlierAlpha Plus
+10.9%+12.6%+0.7%
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
+0.9%+23.9%−1.4%
+1.4%+24.5%−8.6%
−17.5%−2.3%−28.7%
−17.4%−5.4%−30.3%
+66.1%+19.6%+38.7%
+3.4%+3.8%+57.6%
−218.1%+772.3%+4.0%
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

NEOGEN₹2,261.70

NEOGEN CHEMICALS LTD.

· Chemicals
₹ CrorePeersTATACHEMAETHERNFLLXCHEMPRIVISCLRAINRALLISRCFMcap ₹5,966 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Revenue Growth—+0.7+12.6+10.9—
EBITDA Growth—-1.4+23.9+0.9—
EBIT Growth—-8.6+24.5+1.4—
Net Income Growth—-28.7-2.3-17.5—
EPS Growth—-30.3-5.4-17.4—
Total Assets Growth—+38.7+19.6+66.1—
Total Equity Growth—+57.6+3.8+3.4—
Cash from Operations Growth—+4.0+772.3-218.1—
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.